Association between genetically proxied glucosamine and risk of cancer and non-neoplastic disease: A Mendelian randomization study

被引:0
|
作者
Wu, Yingtong [1 ,2 ]
Che, Yinggang [1 ]
Zhang, Yong [1 ]
Xiong, Yanlu [3 ]
Shu, Chen [3 ]
Jiang, Jun [4 ]
Li, Gaozhi [5 ]
Guo, Lin [6 ]
Qiao, Tianyun [3 ]
Li, Shuwen [2 ]
Li, Ou [2 ]
Chang, Ning [1 ]
Zhang, Xinxin [7 ]
Zhang, Minzhe [1 ]
Qiu, Dan [1 ]
Xi, Hangtian [1 ]
Li, Jinggeng [1 ]
Chen, Xiangxiang [1 ]
Ye, Mingxiang [8 ]
Zhang, Jian [1 ]
机构
[1] Air Force Med Univ, Xijing Hosp, Dept Pulm & Crit Care Med, Xian, Peoples R China
[2] Air Force Healthcare Ctr Special Serv, Sanat 1, Hangzhou, Peoples R China
[3] Air Force Med Univ, Tangdu Hosp, Dept Thorac Surg, Xian, Peoples R China
[4] Air Force Med Univ, Dept Hlth Serv, Xian, Peoples R China
[5] Peoples Liberat Army, Unit 94498, Nanyang, Peoples R China
[6] Air Force Med Univ, Tangdu Hosp, Dept Obstet & Gynecol, Xian, Peoples R China
[7] Chinese Peoples Liberat Army Gen Hosp, Coll Pulm & Crit Care Med, Med Ctr 8, Beijing, Peoples R China
[8] Nanjing Univ, Jinling Hosp, Sch Med, Dept Resp Med, Nanjing, Peoples R China
基金
中国国家自然科学基金;
关键词
glucosamine; cancer risk; Mendelian randomization; single-nucleotide polymorphisms; causality; PAIN-RELATED DISABILITY; CHONDROITIN SULFATE; CELLS; INHIBITION; EXPRESSION; PROTEIN; AUTOPHAGY; OSTEOARTHRITIS; SUSCEPTIBILITY; HYDROCHLORIDE;
D O I
10.3389/fgene.2024.1293668
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Introduction Observational investigations have examined the impact of glucosamine use on the risk of cancer and non-neoplastic diseases. However, the findings from these studies face limitations arising from confounding variables, reverse causation, and conflicting reports. Consequently, the establishment of a causal relationship between habitual glucosamine consumption and the risk of cancer and non-neoplastic diseases necessitates further investigation.Methods For Mendelian randomization (MR) investigation, we opted to employ single-nucleotide polymorphisms (SNPs) as instruments that exhibit robust associations with habitual glucosamine consumption. We obtained the corresponding effect estimates of these SNPs on the risk of cancer and non-neoplastic diseases by extracting summary data for genetic instruments linked to 49 varied cancer types amounting to 378,284 cases and 533,969 controls, as well as 20 non-neoplastic diseases encompassing 292,270 cases and 842,829 controls. Apart from the primary analysis utilizing inverse-variance weighted MR, we conducted two supplementary approaches to account for potential pleiotropy (MR-Egger and weighted median) and assessed their respective MR estimates. Furthermore, the results of the leave-one-out analysis revealed that there were no outlying instruments.Results Our results suggest divergence from accepted biological understanding, suggesting that genetically predicted glucosamine utilization may be linked to an increased vulnerability to specific illnesses, as evidenced by increased odds ratios and confidence intervals (95% CI) for diseases, such as malignant neoplasm of the eye and adnexa (2.47 [1.34-4.55]), benign neoplasm of the liver/bile ducts (2.12 [1.32-3.43]), benign neoplasm of the larynx (2.01 [1.36-2.96]), melanoma (1.74 [1.17-2.59]), follicular lymphoma (1.50 [1.06-2.11]), autoimmune thyroiditis (2.47 [1.49-4.08]), and autoimmune hyperthyroidism (1.93 [1.17-3.18]). In contrast to prior observational research, our genetic investigations demonstrate a positive correlation between habitual glucosamine consumption and an elevated risk of sigmoid colon cancer, lung adenocarcinoma, and benign neoplasm of the thyroid gland.Conclusion Casting doubt on the purported purely beneficial association between glucosamine ingestion and prevention of neoplastic and non-neoplastic diseases, habitual glucosamine ingestion exhibits dichotomous effects on disease outcomes. Endorsing the habitual consumption of glucosamine as a preventative measure against neoplastic and non-neoplastic diseases cannot be supported.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases A Mendelian Randomization Study
    Haycock, Philip C.
    Burgess, Stephen
    Nounu, Aayah
    Zheng, Jie
    Okoli, George N.
    Bowden, Jack
    Wade, Kaitlin Hazel
    Timpson, Nicholas J.
    Evans, David M.
    Willeit, Peter
    Aviv, Abraham
    Gaunt, Tomr.
    Hemani, Gibran
    Mangino, Massimo
    Ellis, Hayley Patricia
    Kurian, Kathreena M.
    Pooley, Karen A.
    Eeles, Rosalind A.
    Lee, Jeffrey E.
    Fang, Shenying
    Chen, Wei V.
    Law, Matthew H.
    Bowdler, Lisa M.
    Iles, Mark M.
    Yang, Qiong
    Worrall, Bradford B.
    Markus, Hugh Stephen
    Hung, Rayjean J.
    Amos, Chris I.
    Spurdle, Amanda B.
    Thompson, Deborah J.
    O'Mara, Tracy A.
    Wolpin, Brian
    Amundadottir, Laufey
    Stolzenberg-Solomon, Rachael
    Trichopoulou, Antonia
    Onland-Moret, Charlotte
    Lund, Eiliv
    Duell, Eric J.
    Canzian, Federico
    Severi, Gianluca
    Overvad, Kim
    Gunter, Marc J.
    Tumino, Rosario
    Svenson, Ulrika
    van Rij, Andre
    Baas, Annette F.
    Bown, Matthew J.
    Samani, Nilesh J.
    van t'Hof, Femke N. G.
    JAMA ONCOLOGY, 2017, 3 (05) : 636 - 651
  • [2] Association between genetically proxied PPARG activation and psoriasis vulgaris: a Mendelian randomization study
    Xue, Yan
    Xia, Yuning
    Cheng, Donghao
    Shi, Taiyu
    Mei, Ping
    Hong, Sheng
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2024, 35 (01)
  • [3] Association between non-neoplastic bladder diseases and bladder cancer risk: insights from Mendelian randomization studies
    Zhang, Yi
    Li, Rongkang
    Zhang, Shaohua
    Li, Hangxu
    POSTGRADUATE MEDICAL JOURNAL, 2024, 101 (1192) : 156 - 162
  • [4] Relationship between genetically proxied vitamin D and psoriasis risk: a Mendelian randomization study
    Bohmann, Patricia
    Stein, Michael J.
    Konzok, Julian
    Tsoi, Lam C.
    Elder, James T.
    Leitzmann, Michael F.
    Baumeister, Sebastian-Edgar
    Baurecht, Hansjoerg
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2023, 48 (06) : 642 - 647
  • [5] Genetically Proxied Inhibition of Coagulation Factors and Risk of Cardiovascular Disease: A Mendelian Randomization Study
    Yuan, Shuai
    Burgess, Stephen
    Laffan, Mike
    Mason, Amy M.
    Dichgans, Martin
    Gill, Dipender
    Larsson, Susanna C.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (08):
  • [6] Association between genetically proxied HMGCR inhibition and male reproductive health: A Mendelian randomization study
    Yan, Zhaoqi
    Xu, Yifeng
    Li, Keke
    Liu, Liangji
    MEDICINE, 2023, 102 (39) : E34690
  • [7] Association between genetically proxied PCSK9 inhibition and systemic lupus erythematosus risk: A mendelian randomization study
    Ji, Xincan
    Guo, Hao-Yang
    Han, Mengqi
    Peng, Hui
    Yuan, Hui
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2024, 27 (04)
  • [8] Association Between Genetically Proxied SLC12A2 Inhibition and Inflammatory Bowel Disease: A Mendelian Randomization Study
    Yu, Xin
    Cao, Yongsheng
    Mao, Changkun
    Tao, Chengpin
    Chen, Wei
    BIOCHEMICAL GENETICS, 2025,
  • [9] Genetically Proxied Interleukin-13 Inhibition Is Associated With Risk of Psoriatic Disease: A Mendelian Randomization Study
    Zhao, Sizheng Steven
    Hyrich, Kimme
    Yiu, Zenas
    Barton, Anne
    Bowes, John
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 (11) : 1602 - 1610
  • [10] Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study
    Fang, Si M.
    Yarmolinsky, James
    Gill, Dipender R.
    Bull, Caroline G.
    Perks, Claire
    Smith, George Davey
    Gaunt, Tom
    Richardson, Tom
    PLOS MEDICINE, 2023, 20 (01)